Samsun Liv Hospital
8
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Assessment of Complications in Patients Who Underwent LPN According to the CCI
Role: lead
The Learning Curve for Retroperitoneoscopic Donor Nephrectomy
Role: lead
LPN in Patients With High-complex Renal Tumors
Role: lead
Direct Use of Non-centrifuged Autologous Fat Graft
Role: lead
Laparoscopic Partial Nephrectomy for cT1 Tumors
Role: lead
Laparoscopic Adrenalectomy for Large Adrenal Tumors.
Role: lead
Retroperitoneoscopic Donor Nephrectomy
Role: lead
Effects of Tadalafil on LMR and MHR in Patients With ED
Role: lead
All 8 trials loaded